HeadlinesBriefing favicon HeadlinesBriefing.com

Bank of England Fines Direct Line £10.6M Over Capital Overstatement

Financial Times Companies •
×

Bank of England imposes a £10.6 million fine on UK insurer Direct Line for overstating its capital by nearly £100 million. The error stemmed from miscalculations in a 2023 reinsurance arrangement called Project Athena, which inflated the company’s reported funds. Regulator Prudential Regulation Authority (PRA) cited “ineffective controls” in Direct Line’s finance and actuarial teams as the root cause. While Direct Line admitted the mistake early, reducing the penalty from £21.3 million, the PRA emphasized that the firm had “significantly less headroom” than disclosed, risking its solvency ratio—a key metric for insurers.

The miscalculation unfolded over 2023, with Direct Line initially reporting a solvency ratio of 197% (well above the 140-180% regulatory range). However, the PRA revealed the true figure was 188%, leaving the company with only 8% more capital than required. The error compounded as the firm failed to detect the £99.9 million overstatement until late 2023, a year before parent company Aviva finalized its acquisition. Aviva acknowledged the issue was “fully provided for” in the deal’s financials but noted it accelerated post-acquisition controls to address reporting gaps.

Direct Line’s proactive disclosure and remediation efforts mitigated the penalty, marking the first use of the PRA’s early account scheme. The regulator praised the firm’s cooperation but stressed the importance of robust financial controls. Aviva reiterated that the fine “has no impact” on its integration plans or projected benefits from the acquisition, which it views as strategically sound despite the hiccup.

This case underscores heightened scrutiny of insurers’ capital reporting ahead of major corporate deals. With Project Athena’s fallout spotlighting systemic risks, analysts warn similar oversights could trigger broader market instability. For now, Direct Line’s swift corrective actions and Aviva’s contingency planning appear to contain the damage, though regulatory vigilance remains paramount.